• Explore /
  • Poster
  • / First results of the PROMPT trial: Precision oncology allocation in patients with early castration-resistant prostate cancer following routine molecular profiling.

First results of the PROMPT trial: Precision oncology allocation in patients with early castration-resistant prostate cancer following routine molecular profiling.

Abstract Poster

Authors

null

Iris S. H. Kloots

Department of Medical Oncology, Radboud University Medical Center, Nijmegen, Netherlands

Iris S. H. Kloots , Peter H.J. Slootbeek , Minke Smits , Sjoerd van Helvert , Leonie I. Kroeze , Marleen Kets , Katrien Grünberg , Jolique van Ipenburg , Marjolijn Ligtenberg , Jack A. Schalken , Inge M. van Oort , Haiko Bloemendal , Winald R. Gerritsen , Niven Mehra

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Diagnostics and Imaging

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 40)

DOI

10.1200/JCO.2022.40.6_suppl.040

Abstract #

40

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Mehdi Brahmi

First Author: Jessica Tao

First Author: Edmond Michael Kwan

First Author: Clara Hwang